10.60Open10.60Pre Close2 Volume0 Open Interest86.00Strike Price2.12KTurnover0.00%IV1.32%PremiumDec 20, 2024Expiry Date9.59Intrinsic Value100Multiplier3DDays to Expiry1.01Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma8.26Leverage Ratio--Theta--Rho--Eff Leverage--Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet